|
|
The word 'oncology' encompasses a large number of indications and drug classes.
Research Matters directors have perhaps an unequalled breadth and depth of experience in oncology, having
conducted projects for virtually every type of solid and hematological cancer, working with many of the
world's top oncology companies for over 15 years.
Research Matters develops treatment algorithms and tracks developments in the treatment of specific
cancer types (breast, colorectal and lung) on an ad-hoc basis and through multi-client studies.
Three multi-client studies conducted annually are:
- Breast Cancer Treatment Tracker (US, UK, Ge, Fr, It, Sp)
- Non-Small Cell Lung Cancer Treatment Tracker (US, JA, UK, Ge, Fr, It, Sp)
- Colorectal Cancer Treatment Tracker (US, Ja UK, Ge, Fr, It, Sp)
Research Matters regularly attends international oncology conferences and meetings
(e.g. ASCO, ECCO, ESMO, ASH, EHA).
Research Matters also operates an exclusive Oncopanel providing access to oncologists from the main European countries and the USA.
|